Henry Schein, Inc. (NASDAQ:HSIC) to Post Q3 2024 Earnings of $1.16 Per Share, Zacks Research Forecasts

Henry Schein, Inc. (NASDAQ:HSIC – Free Report) – Zacks Research cut their Q3 2024 EPS estimates for shares of Henry Schein in a research report issued on Friday, September 13th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $1.16 per share for the quarter, down from their previous estimate [...]

featured-image

Henry Schein, Inc. ( NASDAQ:HSIC – Free Report ) – Zacks Research cut their Q3 2024 EPS estimates for shares of Henry Schein in a research report issued on Friday, September 13th. Zacks Research analyst R.

Department now forecasts that the company will post earnings of $1.16 per share for the quarter, down from their previous estimate of $1.21.



The consensus estimate for Henry Schein’s current full-year earnings is $4.75 per share. Zacks Research also issued estimates for Henry Schein’s FY2024 earnings at $4.

73 EPS, Q3 2025 earnings at $1.36 EPS, FY2025 earnings at $5.20 EPS and FY2026 earnings at $5.

68 EPS. HSIC has been the subject of a number of other research reports. Robert W.

Baird dropped their price objective on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th.

UBS Group cut their price target on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a report on Wednesday, August 7th.

Barrington Research cut their target price on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research note on Wednesday, August 7th.

Baird R W upgraded shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $86.00 target price on shares of Henry Schein in a research report on Friday, June 21st.

One research analyst has rated the stock with a sell rating, six have issued a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Henry Schein presently has a consensus rating of “Hold” and a consensus price target of $77.

10. Henry Schein Trading Up 3.2 % Shares of HSIC opened at $70.

38 on Monday. The firm has a 50 day simple moving average of $69.21 and a 200-day simple moving average of $70.

52. The stock has a market cap of $8.92 billion, a price-to-earnings ratio of 23.

78, a price-to-earnings-growth ratio of 1.88 and a beta of 0.86.

The company has a debt-to-equity ratio of 0.46, a current ratio of 1.55 and a quick ratio of 0.

90. Henry Schein has a 1-year low of $60.01 and a 1-year high of $82.

63. Henry Schein ( NASDAQ:HSIC – Get Free Report ) last issued its earnings results on Tuesday, August 6th. The company reported $1.

23 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.01.

Henry Schein had a net margin of 2.82% and a return on equity of 13.19%.

The business had revenue of $3.10 billion for the quarter, compared to the consensus estimate of $3.27 billion.

During the same quarter in the previous year, the firm earned $1.31 earnings per share. The business’s quarterly revenue was up .

0% compared to the same quarter last year. Insider Transactions at Henry Schein In other news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.

30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at $4,978,026.

90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink . 1.

14% of the stock is currently owned by company insiders. Hedge Funds Weigh In On Henry Schein Institutional investors have recently modified their holdings of the stock. BNP Paribas Financial Markets lifted its position in Henry Schein by 36.

0% during the 4th quarter. BNP Paribas Financial Markets now owns 82,517 shares of the company’s stock valued at $6,247,000 after purchasing an additional 21,838 shares during the period. ING Groep NV increased its position in shares of Henry Schein by 9.

0% in the 4th quarter. ING Groep NV now owns 17,877 shares of the company’s stock valued at $1,353,000 after buying an additional 1,483 shares in the last quarter. Norges Bank bought a new position in Henry Schein during the fourth quarter worth about $111,715,000.

MainStreet Investment Advisors LLC raised its holdings in Henry Schein by 8.5% during the 4th quarter. MainStreet Investment Advisors LLC now owns 6,519 shares of the company’s stock worth $494,000 after buying an additional 508 shares during the period.

Finally, PNC Financial Services Group Inc. raised its position in Henry Schein by 5.6% in the 4th quarter.

PNC Financial Services Group Inc. now owns 87,085 shares of the company’s stock valued at $6,593,000 after buying an additional 4,591 shares during the last quarter. 96.

62% of the stock is owned by institutional investors. Henry Schein Company Profile ( Get Free Report ) Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Stories Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter ..